Analysts often have a good sense about the development of stocks due to their intensive research related to the company.
Not all analysts predict the correct economic development but they do a very good basic desk research and they have conversations with the management teams of the company, so not many people a as good informed as analysts.
Today I've listed all stocks with more than 10 years of consecutive dividend growth (Dividend Achievers) and a strong buy rating. Only nine companies have received the highest buy rating by analysts. Six of them are listed on the technology stock exchange NASDAQ.
Only four firms have a market capitalization over one billion US-Dollar. Keep in mind that those stocks also contain a higher risk for invvestors.
The only 9 Dividend Achievers with a strong buy rating are....
Vector Group (NYSE:VGR) has a market capitalization of $2.08 billion. The company employs 989 people, generates revenue of $1,056.20 million and has a net income of $38.69 million. Vector Group’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $212.77 million. The EBITDA margin is 20.15 percent (the operating margin is 13.16 percent and the net profit margin 3.66 percent).
Financial Analysis: The total debt represents 54.94 percent of Vector Group’s assets and the total debt in relation to the equity amounts to percent. Due to the financial situation, a return on equity of percent was realized by Vector Group. Twelve trailing months earnings per share reached a value of $0.44. Last fiscal year, Vector Group paid $1.54 in the form of dividends to shareholders.
Market Valuation: Here are the price ratios of the company: The P/E ratio is 47.03, the P/S ratio is 1.97 and the P/B ratio is finally . The dividend yield amounts to 7.67 percent and the beta ratio has a value of 0.27.
 |
| Long-Term Stock Price Chart Of Vector Group (VGR) |
 |
| Long-Term Dividend Payment History of Vector Group (VGR) |
 |
| Long-Term Dividend Yield History of Vector Group (VGR) |
BHP Billiton (NYSE:BBL) has a market capitalization of $71.03 billion. The company employs 49,496 people, generates revenue of $65,953.00 million and has a net income of $12,820.00 million. BHP Billiton’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $28,819.00 million. The EBITDA margin is 43.70 percent (the operating margin is 31.84 percent and the net profit margin 19.44 percent).
Financial Analysis: The total debt represents 23.84 percent of BHP Billiton’s assets and the total debt in relation to the equity amounts to 46.96 percent. Due to the financial situation, a return on equity of 16.44 percent was realized by BHP Billiton. Twelve trailing months earnings per share reached a value of $5.58. Last fiscal year, BHP Billiton paid $2.32 in the form of dividends to shareholders.
Market Valuation: Here are the price ratios of the company: The P/E ratio is 12.06, the P/S ratio is 2.79 and the P/B ratio is finally 1.01. The dividend yield amounts to 3.51 percent and the beta ratio has a value of 1.70.
 |
| Long-Term Stock Price Chart Of BHP Billiton (BBL) |
 |
| Long-Term Dividend Payment History of BHP Billiton (BBL) |
 |
| Long-Term Dividend Yield History of BHP Billiton (BBL) |
Span-America Medical Systems (NASDAQ:SPAN) has a market capitalization of $58.09 million. The company employs 275 people, generates revenue of $73.83 million and has a net income of $5.07 million. Span-America Medical Systems’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $8.58 million. The EBITDA margin is 11.62 percent (the operating margin is 9.88 percent and the net profit margin 6.86 percent).
Financial Analysis: The total debt represents 0.00 percent of Span-America Medical Systems’s assets and the total debt in relation to the equity amounts to 0.00 percent. Due to the financial situation, a return on equity of 16.84 percent was realized by Span-America Medical Systems. Twelve trailing months earnings per share reached a value of $1.34. Last fiscal year, Span-America Medical Systems paid $0.38 in the form of dividends to shareholders.
Market Valuation: Here are the price ratios of the company: The P/E ratio is 14.60, the P/S ratio is 0.79 and the P/B ratio is finally 1.91. The dividend yield amounts to 2.85 percent and the beta ratio has a value of 0.46.
 |
| Long-Term Stock Price Chart Of Span-America Medical Systems (SPAN) |
 |
| Long-Term Dividend Payment History of Span-America Medical Systems (SPAN) |
 |
| Long-Term Dividend Yield History of Span-America Medical Systems (SPAN) |
Eagle Bancorp Montana (NASDAQ:EBMT) has a market capitalization of $42.32 million. The company employs 185 people, generates revenue of $14.80 million and has a net income of $1.97 million. Eagle Bancorp Montana’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $6.34 million. The EBITDA margin is 28.03 percent (the operating margin is 5.85 percent and the net profit margin 8.73 percent).
Financial Analysis: The total debt represents 1.01 percent of Eagle Bancorp Montana’s assets and the total debt in relation to the equity amounts to 10.47 percent. Due to the financial situation, a return on equity of 3.84 percent was realized by Eagle Bancorp Montana. Twelve trailing months earnings per share reached a value of $0.49. Last fiscal year, Eagle Bancorp Montana paid $0.29 in the form of dividends to shareholders.
Market Valuation: Here are the price ratios of the company: The P/E ratio is 22.15, the P/S ratio is 1.87 and the P/B ratio is finally 0.86. The dividend yield amounts to 2.69 percent and the beta ratio has a value of 0.33.
 |
| Long-Term Stock Price Chart Of Eagle Bancorp Montana (EBMT) |
 |
| Long-Term Dividend Payment History of Eagle Bancorp Montana (EBMT) |
 |
| Long-Term Dividend Yield History of Eagle Bancorp Montana (EBMT) |
Utah Medical Products (NASDAQ:UTMD) has a market capitalization of $186.14 million. The company employs 177 people, generates revenue of $40.49 million and has a net income of $11.41 million. Utah Medical Products’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $18.02 million. The EBITDA margin is 44.51 percent (the operating margin is 36.62 percent and the net profit margin 28.17 percent).
Financial Analysis: The total debt represents 11.30 percent of Utah Medical Products’s assets and the total debt in relation to the equity amounts to 15.05 percent. Due to the financial situation, a return on equity of 20.45 percent was realized by Utah Medical Products. Twelve trailing months earnings per share reached a value of $3.01. Last fiscal year, Utah Medical Products paid $0.98 in the form of dividends to shareholders.
Market Valuation: Here are the price ratios of the company: The P/E ratio is 16.46, the P/S ratio is 4.60 and the P/B ratio is finally 3.06. The dividend yield amounts to 2.02 percent and the beta ratio has a value of 0.29.
 |
| Long-Term Stock Price Chart Of Utah Medical Products (UTMD) |
 |
| Long-Term Dividend Payment History of Utah Medical Products (UTMD) |
 |
| Long-Term Dividend Yield History of Utah Medical Products (UTMD) |
Acme United (NYSEMKT:ACU) has a market capitalization of $54.35 million. The company employs 180 people, generates revenue of $89.58 million and has a net income of $4.00 million. Acme United’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $7.08 million. The EBITDA margin is 7.91 percent (the operating margin is 6.56 percent and the net profit margin 4.47 percent).
Financial Analysis: The total debt represents 33.65 percent of Acme United’s assets and the total debt in relation to the equity amounts to 65.45 percent. Due to the financial situation, a return on equity of 12.15 percent was realized by Acme United. Twelve trailing months earnings per share reached a value of $1.23. Last fiscal year, Acme United paid $0.31 in the form of dividends to shareholders.
Market Valuation: Here are the price ratios of the company: The P/E ratio is 13.76, the P/S ratio is 0.61 and the P/B ratio is finally 1.55. The dividend yield amounts to 1.89 percent and the beta ratio has a value of 0.40.
 |
| Long-Term Stock Price Chart Of Acme United (ACU) |
 |
| Long-Term Dividend Payment History of Acme United (ACU) |
 |
| Long-Term Dividend Yield History of Acme United (ACU) |
Raven Industries (NASDAQ:RAVN) has a market capitalization of $1.14 billion. The company employs 1,286 people, generates revenue of $394.68 million and has a net income of $42.90 million. Raven Industries’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $78.19 million. The EBITDA margin is 19.81 percent (the operating margin is 16.21 percent and the net profit margin 10.87 percent).
Financial Analysis: The total debt represents 0.00 percent of Raven Industries’s assets and the total debt in relation to the equity amounts to 0.00 percent. Due to the financial situation, a return on equity of 18.15 percent was realized by Raven Industries. Twelve trailing months earnings per share reached a value of $1.09. Last fiscal year, Raven Industries paid $0.48 in the form of dividends to shareholders.
Market Valuation: Here are the price ratios of the company: The P/E ratio is 28.74, the P/S ratio is 2.89 and the P/B ratio is finally 4.53. The dividend yield amounts to 1.53 percent and the beta ratio has a value of 0.75.
 |
| Long-Term Stock Price Chart Of Raven Industries (RAVN) |
 |
| Long-Term Dividend Payment History of Raven Industries (RAVN) |
 |
| Long-Term Dividend Yield History of Raven Industries (RAVN) |
J&J Snack Foods (NASDAQ:JJSF) has a market capitalization of $1.76 billion. The company employs 3,400 people, generates revenue of $867.68 million and has a net income of $64.38 million. J&J Snack Foods’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $131.46 million. The EBITDA margin is 15.15 percent (the operating margin is 11.23 percent and the net profit margin 7.42 percent).
Financial Analysis: The total debt represents 0.05 percent of J&J Snack Foods’s assets and the total debt in relation to the equity amounts to 0.07 percent. Due to the financial situation, a return on equity of 12.98 percent was realized by J&J Snack Foods. Twelve trailing months earnings per share reached a value of $3.58. Last fiscal year, J&J Snack Foods paid $0.61 in the form of dividends to shareholders.
Market Valuation: Here are the price ratios of the company: The P/E ratio is 26.37, the P/S ratio is 2.03 and the P/B ratio is finally 3.41. The dividend yield amounts to 1.36 percent and the beta ratio has a value of 0.55.
 |
| Long-Term Stock Price Chart Of J&J Snack Foods (JJSF) |
 |
| Long-Term Dividend Payment History of J&J Snack Foods (JJSF) |
 |
| Long-Term Dividend Yield History of J&J Snack Foods (JJSF) |
Mesa Laboratories (NASDAQ:MLAB) has a market capitalization of $281.70 million. The company employs 273 people, generates revenue of $52.72 million and has a net income of $9.00 million. Mesa Laboratories’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $15.63 million. The EBITDA margin is 29.64 percent (the operating margin is 22.35 percent and the net profit margin 17.07 percent).
Financial Analysis: The total debt represents 16.92 percent of Mesa Laboratories’s assets and the total debt in relation to the equity amounts to 25.65 percent. Due to the financial situation, a return on equity of 15.37 percent was realized by Mesa Laboratories. Twelve trailing months earnings per share reached a value of $2.48. Last fiscal year, Mesa Laboratories paid $0.58 in the form of dividends to shareholders.
Market Valuation: Here are the price ratios of the company: The P/E ratio is 32.37, the P/S ratio is 5.34 and the P/B ratio is finally 4.36. The dividend yield amounts to 0.75 percent and the beta ratio has a value of 0.53.
 |
| Long-Term Stock Price Chart Of Mesa Laboratories (MLAB) |
 |
| Long-Term Dividend Payment History of Mesa Laboratories (MLAB) |
 |
| Long-Term Dividend Yield History of Mesa Laboratories (MLAB) |
*I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I receive no compensation to write about any specific stock, sector or theme.
This article was written by Dividend Yield. If you enjoyed this article, please subscribe to his feed [RSS].
